院外心脏骤停的骨内或静脉血管通路
一项随机临床试验比较成人非创伤性院外心脏骤停初始骨内或静脉血管通路的有效性,主要结局为持续自主循环恢复。共1506例随机分组,1479例纳入主要分析(骨内组731例,静脉组748例)。骨内组与静脉组持续自主循环恢复无显著差异(30% vs 29%;风险比1.06;95%CI 0.90至1.24;P=0.49)。
要点
- 骨内组与静脉组持续自主循环恢复无显著差异(30% vs 29%;风险比1.06;95%CI 0.90至1.24;P=0.49)。
- 骨内组两次内成功建立血管通路669例(92%),静脉组595例(80%)。
- 30天生存率骨内组12% vs 静脉组10%(风险比1.16;95%CI 0.87至1.56),无显著差异。
核心结论
- 成人院外心脏骤停初始骨内与静脉血管通路在持续自主循环恢复方面无显著差异。
研究设计与样本
- 随机临床试验,比较成人非创伤性院外心脏骤停初始骨内或静脉血管通路的有效性;1506例随机分组,1479例纳入主要分析(骨内组731例,静脉组748例)。
主要发现
- 两次内成功建立血管通路:骨内组669例(92%)vs 静脉组595例(80%)。
- 持续自主循环恢复:骨内组221例(30%)vs 静脉组214例(29%);风险比1.06;95%CI 0.90至1.24;P=0.49。
- 30天生存:骨内组85例(12%)vs 静脉组75例(10%);风险比1.16;95%CI 0.87至1.56。
- 30天神经功能良好结局(改良Rankin量表评分0至3分):骨内组67例(9%)vs 静脉组59例(8%);风险比1.16;95%CI 0.83至1.62。
- 预设不良事件不常见。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Out-of-hospital cardiac arrest is a leading cause of death worldwide. Establishing vascular access is critical for administering guideline-recommended drugs during cardiopulmonary resuscitation. Both the intraosseous route and the intravenous route are used routinely, but their comparative effectiveness remains unclear. METHODS: We conducted a randomized clinical trial to compare the effectiveness of initial attempts at intraosseous or intravenous vascular access in adults who had nontraumatic out-of-hospital cardiac arrest. The primary outcome was a sustained return of spontaneous circulation. Key secondary outcomes were survival at 30 days and survival at 30 days with a favorable neurologic outcome, defined by a score of 0 to 3 on the modified Rankin scale (scores range from 0 to 6, with higher scores indicating greater disability). RESULTS: Among 1506 patients who underwent randomization, 1479 were included in the primary analysis (731 in the intraosseous-access group and 748 in the intravenous-access group). The successful establishment of vascular access within two attempts occurred in 669 patients (92%) assigned to the intraosseous-access group and in 595 patients (80%) assigned to the intravenous-access group. Sustained return of spontaneous circulation occurred in 221 patients (30%) in the intraosseous-access group and in 214 patients (29%) in the intravenous-access group (risk ratio, 1.06; 95% confidence interval [CI], 0.90 to 1.24; P = 0.49). At 30 days, 85 patients (12%) in the intraosseous-access group and 75 patients (10%) in the intravenous-access group were alive (risk ratio, 1.16; 95% CI, 0.87 to 1.56); a favorable neurologic outcome at 30 days occurred in 67 patients (9%) and 59 patients (8%), respectively (risk ratio, 1.16; 95% CI, 0.83 to 1.62). Prespecified adverse events were uncommon. CONCLUSIONS: There was no significant difference in sustained return of spontaneous circulation between initial intraosseous and intravenous vascular access in adults who had out-of-hospital cardiac arrest. (Funded by the Novo Nordisk Foundation and others; IVIO EU Clinical Trials Register number, 2022-500744-38-00; ClinicalTrials.gov number, NCT05205031.).
引用
- Vallentin MF, Granfeldt A, Klitgaard TL, et al. Intraosseous or Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest. N Engl J Med. 2024. PMID: 39480221. doi:10.1056/NEJMoa2407616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。